Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?
Related Questions
How do you approach rising PSA following radical prostatectomy and early salvage radiation therapy?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
Is there any evidence for combining surgery and XRT +/- ADT for treatment of localized high risk prostate cancer?
For gross hematuria from a primary bladder tumor, what palliative radiation regimen would you recommend?
Does long term use of 5 alpha reductase inhibitors change the way you evaluate a PSMA PET?
How would you manage T3N0M0 sarcomatoid carcinoma of the prostate with Adenosquamous differentiation s/p prostatectomy?
Given the PATRIOT trial and hypo-FLAME 2.0, do you consider once-a-week prostate SBRT instead of every other day?
For a patient with a rising PSA after prostatectomy with seminal vesicles being negative for disease at surgery, do you ever treat the prostate bed and seminal vesicle bed with different doses in an SIB plan?
How do you incorporate absolute percent pattern 4 (APP4) into your risk stratification, specifically your recommendation for ADT for intermediate prostate cancer?
Is there any evidence for amyloid/amyloidosis causing a spurious/false PSA reading?
